Discontinued — last reported Q4 '25
Prepaid & Other Current
Pfizer Prepaid & Other Current increased by 19.1% to $2.81B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 34.0%, from $4.25B to $2.81B. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows a downward trend with a -5.1% CAGR.
Analysis
How to read this metric
Significant fluctuations may indicate changes in corporate procurement cycles or shifts in accounting for short-term financial instruments.
Detailed definition
Payments made in advance for services or goods to be received within the next year, alongside other miscellaneous short-...
Peer comparison
Generally a small percentage of current assets; large spikes may warrant investigation into non-recurring items.
prepaid_and_other_current_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.82B | $3.79B | $3.82B | $4.20B | $5.97B | $6.15B | $5.02B | $5.12B | $4.83B | $4.62B | $4.91B | $4.37B | $4.19B | $3.86B | $4.25B | $2.95B | $2.69B | $2.36B | $2.81B |
| QoQ Change | — | -0.7% | +0.8% | +10.0% | +42.1% | +3.0% | -18.4% | +2.1% | -5.7% | -4.2% | +6.2% | -11.0% | -4.2% | -8.0% | +10.3% | -30.7% | -8.7% | -12.3% | +19.1% |
| YoY Change | — | — | — | — | +56.4% | +62.2% | +31.3% | +21.8% | -19.1% | -24.8% | -2.1% | -14.6% | -13.2% | -16.6% | -13.4% | -32.6% | -35.8% | -38.8% | -34.0% |
Product Breakdown
| Segment | Q2 '24 |
|---|---|
| Comirnaty | $275.00M |
| Total | $4.19B |
Comirnaty was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Pfizer's prepaid & other current?
- Pfizer (PFE) reported prepaid & other current of $2.81B in Q4 2025.
- How has Pfizer's prepaid & other current changed year-over-year?
- Pfizer's prepaid & other current decreased by 34.0% year-over-year, from $4.25B to $2.81B.
- What is the long-term trend for Pfizer's prepaid & other current?
- Over 5 years (2020 to 2025), Pfizer's prepaid & other current has grown at a -5.1% compound annual growth rate (CAGR), from $3.65B to $2.81B.
- What does prepaid & other current mean?
- Assets representing payments made for future services or miscellaneous short-term holdings.